The National Agency For Food And Drug Administration And Control (NAFDAC), has certified the use of GLUCOZIL for the treatment of diabetes mellitus.
GLUCOZIL, a herbal drug, is produced by Ambrose Alli University Ekpoma.
NAFDAC’s approval of the drug for public use was announced in a statement by Mike Aladenika, AAU spokesman.
“Its bid to reclaim its enviable position among the comity of institutions, grounded in research and higher learning, has received the approval of NAFDAC, as well as the rights of production and patents of GLUCOZIL,” said the statement.
Jonathan Emeka Emordi, head of the university’s pharmacology department, and sub-dean of Basic Clinical Sciences, College of Medicine, who produced the drug, said, “GLUCOZIL is a natural product that is prepared for the treatment of diabetes mellitus. GLUCOZIL as a natural product, manufactured to cause a regeneration of the better cells that have been destroyed. If the product is used for a very long period, it will not only manage diabetes but cure it completely.”
According to Mr Emordi, GLUCOZIL which can be used for the management, treatment and cure of diabetes, has bonus clinical indications for the treatment of BPH, commonly known as enlarged prostate.
“In my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided. The product is scientifically tested, right dose confirmed, safety proven in both humans and animals,” Mr Emordi explained.”It is also capable of flushing the human system. Simply put, it is a detoxifier. It has strong anti-oxidant and anti-inflammatory activities which makes it an immune booster.”
Commending Mr Emordi, AAU acting vice-chancellor Sonnie Adagbonyin, said the management was happy with the feat achieved at the College of Medicine and the Department of Pharmacology.
(NAN)
